Concepedia

Publication | Open Access

Off-label use of rituximab for systemic lupus erythematosus in Europe

DOIFull Paper Access

65

Citations

39

References

2016

Year

Monica Rydén‐Aulin, Dimitrios T. Boumpas, Irene E. M. Bultink, José Luís Callejas Rubio, Luis Caminal‐Montero, Antoni Castro, Agustín Colodro Ruiz, Andrea Doria, Thomas Dörner, Cristina González-Echávarri,
Lupus Science & Medicine

Abstract

RTX use for SLE in Europe is restrictive and appears to be used as a last resort in patients for whom other reasonable options have been exhausted.

References

YearCitations

Page 1